ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a buy rating in a research note issued to investors on Wednesday.

A number of other research analysts have also weighed in on ICUI. Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, ICU Medical currently has an average rating of “Buy” and a consensus price target of $168.67.

ICU Medical Stock Down 0.3 %

ICUI opened at $138.67 on Wednesday. The company has a market capitalization of $3.40 billion, a PE ratio of -30.34 and a beta of 0.86. The firm has a 50-day simple moving average of $146.34 and a two-hundred day simple moving average of $159.75. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical has a 52 week low of $93.36 and a 52 week high of $196.26.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of ICUI. Vanguard Group Inc. boosted its holdings in ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock valued at $416,176,000 after acquiring an additional 17,805 shares during the period. JPMorgan Chase & Co. lifted its position in shares of ICU Medical by 7.4% during the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock worth $109,920,000 after purchasing an additional 49,108 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after purchasing an additional 48,106 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of ICU Medical by 18.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock worth $83,788,000 after purchasing an additional 82,982 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of ICU Medical by 11.1% in the fourth quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier’s stock worth $62,431,000 after purchasing an additional 40,187 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.